Literature DB >> 11792235

Celiac Disease.

Ahmad S. Abdulkarim1, Joseph A. Murray.   

Abstract

Individuals with celiac disease present with a wide array of symptoms and signs. Celiac disease can result in substantial injury to the small intestine, deleterious effects on other organ systems, and an overall doubling of mortality. The role of the gastroenterologist is primarily to make the diagnosis and then to ensure that patients with celiac disease receive up-to-date and accurate instructions on diet. It is our opinion that gastroenterologists should participate in the follow-up of what is in fact a form of inflammatory bowel disease. The failure to identify and treat patients with substantial problems may result in an excess of preventable morbidity and mortality. Intestinal biopsy is the definitive method of making the diagnosis of celiac disease, provided the patient has not excluded gluten from his or her diet, because exclusion of gluten results in negative serologic test results and normal small intestinal biopsy samples. The removal of gluten from the diet can result in a total recovery of gut function and a correction of most other consequences. The response is usually so complete that patients should consider themselves to be basically healthy as long as they stay away from the offending foods. However, the execution and maintenance of the "theoretically simple" exclusion of gluten is difficult. The condition is permanent and mandates adherence to a lifelong gluten-free diet; even small amounts of gluten can result in injury to the intestinal lining. The diet is restrictive and requires the patient to be careful about food choices. Therefore, patient education and motivation are crucial to a successful outcome. The correction of vitamin and mineral deficiencies may be helpful in aiding recovery; vitamin D and calcium supplementation often is recommended. No drug therapy has been proven to suppress the disease.

Entities:  

Year:  2002        PMID: 11792235     DOI: 10.1007/s11938-002-0004-3

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  37 in total

1.  The place of oats in the coeliac diet.

Authors:  A L MOULTON
Journal:  Arch Dis Child       Date:  1959-02       Impact factor: 3.791

2.  Self-management of dietary compliance in coeliac disease by means of ELISA "home test" to detect gluten.

Authors:  J H Skerritt; A S Hill
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

3.  Gluten subfractions in coeliac disease.

Authors:  M J Kendall; R Schneider; P S Cox; C F Hawkins
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

Review 4.  Diet therapy of celiac disease and dermatitis herpetiformis.

Authors:  J A Campbell
Journal:  World Rev Nutr Diet       Date:  1987       Impact factor: 0.575

5.  Azathioprine in refractory sprue.

Authors:  A Vaidya; J Bolanos; C Berkelhammer
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

6.  Lack of cellular and humoral immunological responses to oats in adults with coeliac disease.

Authors:  E K Janatuinen; T A Kemppainen; P H Pikkarainen; K H Holm; V M Kosma; M I Uusitupa; M Mäki; R J Julkunen
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

7.  Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study.

Authors:  P J Wahab; J B Crusius; J W Meijer; J J Uil; C J Mulder
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

8.  Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing.

Authors:  A H Talal; J A Murray; J A Goeken; W I Sivitz
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

Review 9.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Authors:  A Fasano; C Catassi
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.